The EPIC Observational Study

Trial ID or NCT#

NCT00676169

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of this study is to better define risk factors preceding first isolation of Pseudomonas aeruginosa (Pa) from respiratory cultures in cystic fibrosis (CF) lung disease and to better define clinical outcomes associated with acquisition of Pa. This study will also collect and bank DNA samples for current and future studies designed to enhance the understanding of the pathogenesis of CF.

Official Title

Longitudinal Assessment of Risk Factors For and Impact of Pseudomonas Aeruginosa Acquisition and Early Anti-Pseudomonal Treatment in Children With CF

Eligibility Criteria

Ages Eligible for Study: Younger than 12 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Carol Conrad
Terry Robinson

Contact us to find out if this trial is right for you.

Contact

Colleen Dunn
6507360388